|
Apr 10
|
Merck (NYSE:MRK) Faces Multiple Shareholder Proposals Ahead Of Annual Meeting
|
|
Apr 10
|
S&P, Dow Jones Pharma Names Rattled — Again — On Trump's Tariffs Whiplash
|
|
Apr 9
|
Apple, Alibaba, drugmaker stocks: Trending Tickers
|
|
Apr 9
|
Trump says pharmaceutical tariffs may be coming: What to know
|
|
Apr 9
|
Dow Jones, S&P 500 Pharma Names Recover After Trump Backs Off His Tariffs Plan
|
|
Apr 9
|
Trump Tariff News: New Tariffs Begin, China Retaliates; Treasury Yields Spike While Delta, Walmart Pull Guidance
|
|
Apr 8
|
Merck & Co., Inc. (MRK): Among Defensive Stocks Billionaire Ken Fisher is Betting On
|
|
Apr 8
|
Walgreens, CVS, & US drugmakers make big moves: What to know
|
|
Apr 8
|
Q4 Earnings Roundup: Organon (NYSE:OGN) And The Rest Of The Branded Pharmaceuticals Segment
|
|
Apr 1
|
Top Analyst Reports for Amazon, Oracle & Merck
|
|
Apr 1
|
Merck to Hold First-Quarter 2025 Sales and Earnings Conference Call April 24
|
|
Mar 31
|
Does AstraZeneca Have 'One Pill To Rule Them All' In Cholesterol?
|
|
Mar 31
|
Merck (NYSE:MRK) Reports Strong Phase 3 Results For WINREVAIR In PAH Treatment
|
|
Mar 31
|
WINREVAIR™ (sotatercept-csrk) Reduced the Risk of a Composite of All-Cause Death, Lung Transplantation and Hospitalization for Pulmonary Arterial Hypertension (PAH) by 76% Compared to Placebo in the Phase 3 ZENITH Trial
|
|
Mar 29
|
Why Merck & Co. Inc. (MRK) Went Up On Friday?
|
|
Mar 28
|
China Expansion Helps Fuel This AI-Powered Cloud Stock In Rough Market
|
|
Mar 28
|
FDA Accepts Merck's Filing for Subcutaneous Version of Keytruda
|
|
Mar 27
|
Is Merck & Co. (MRK) the Low Volatility Stock to Buy According to Billionaire Ken Fisher?
|
|
Mar 27
|
Merck's Biggest Moneymaker Could Get Even Bigger. But Will It Help Downtrodden Shares?
|
|
Mar 27
|
Merck releases positive data for blockbuster cancer drug
|